Extraordinary Potency: Published research describes Dihexa as active at picomolar concentrations-roughly seven orders of magnitude more potent than BDNF in driving new synapse formation in specific assay conditions
Our process involves meticulous small-batch synthesis and third-party lab testing to guarantee that what's on the label is exactly what's in the vial
Although its precise mechanisms remain incompletely characterized, BPC157 displays exceptional pharmacodynamic potency at nanomolar doses and remarkable biostabilityresisting hydrolysis, enzymatic degradation, and gastric fluid while maintaining activity at room temperature
Tween 60 or 80), talcum, starch, lactose and tragacanth, magnesium stearate, glycerol, propylen glycol, preserving agents, benzyl alcohol, methylhydroxy benzoate and/or oleum arachid hydrogen
& Chalasani, S
CJC-1295/Ipamorelin does not share that status